Healius Limited generates the vast majority of its commercial revenues through its extensive network of specialized pathology laboratories, collection centers, and diagnostic imaging clinics distributed across Australia. The enterprise derives income predominantly from patient testing fees, private medical services, and government-backed healthcare reimbursements tied to national health funding programs. Additionally, the company captures growing secondary revenue streams through specialized contract research operations via Agilex Biolabs, which provides clinical trial testing services to major global biotechnology and pharmaceutical developers.